PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+11.69%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.38B
AUM Growth
+$3.38B
(-2.6%)
Cap. Flow
+$174M
Cap. Flow
% of AUM
5.16%
Top 10 Holdings %
Top 10 Hldgs %
46.51%
Holding
114
New
18
Increased
20
Reduced
21
Closed
14
Top Buys
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$197M |
| 2 |
Orchestra BioMed
OBIO
|
$44.6M |
| 3 |
Sanofi
SNY
|
$41.8M |
| 4 |
Arcellx
ACLX
|
$38.3M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$36.6M |
Top Sells
Sector Composition
| 1 | Healthcare | 99.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VBIV
51
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $15.9M | 0.47% |
52,335,002
| – | – |
|
52
Rocket Pharmaceuticals
RCKT
$358M
| $14.9M | 0.44% |
867,732
-210,472
| -20% | -$3.61M |
|
53
Viking Therapeutics
VKTX
$3.02B
| $14.5M | 0.43% |
+871,747
| New | +$14.5M |
|
54
Mirum Pharmaceuticals
MIRM
$3.75B
| $14.4M | 0.43% |
+601,566
| New | +$14.4M |
|
|
RAIN
55
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $14.4M | 0.43% |
1,648,215
-835,404
| -34% | -$7.3M |
|
56
Artivion
AORT
$2.04B
| $14.2M | 0.42% |
1,085,860
| – | – |
|
57
Axogen
AXGN
$718M
| $13.3M | 0.39% |
1,409,791
+21,665
| +2% | +$205K |
|
58
Intuitive Surgical
ISRG
$158B
| $12.8M | 0.38% |
50,000
+10,000
| +25% | +$2.55M |
|
|
ISEE
59
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $12.2M | 0.36% |
500,000
-87,400
| -15% | -$2.13M |
|
60
Athira Pharma
ATHA
$15.5M
| $12M | 0.35% |
4,797,278
| – | – |
|
61
Cytek Biosciences
CTKB
$501M
| $11.9M | 0.35% |
1,289,534
| – | – |
|
62
Prothena Corp
PRTA
$452M
| $11.5M | 0.34% |
237,646
| – | – |
|
63
Tactile Systems Technology
TCMD
$295M
| $10.5M | 0.31% |
+639,877
| New | +$10.5M |
|
|
FUSN
64
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $10.4M | 0.31% |
+2,759,936
| New | +$10.4M |
|
65
Larimar Therapeutics
LRMR
$337M
| $10.3M | 0.31% |
2,280,709
-579,291
| -20% | -$2.62M |
|
66
Neurocrine Biosciences
NBIX
$13.5B
| $10.1M | 0.3% |
100,050
| – | – |
|
67
Biomea Fusion
BMEA
$114M
| $10.1M | 0.3% |
+325,000
| New | +$10.1M |
|
|
MORF
68
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $9.66M | 0.29% |
256,737
-106,460
| -29% | -$4.01M |
|
|
CMAX
69
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $9.55M | 0.28% |
3,576,040
+446,845
| +14% | +$1.19M |
|
70
Tyra Biosciences
TYRA
$657M
| $7.95M | 0.23% |
494,403
| – | – |
|
|
BLPH
71
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $7.34M | 0.22% |
+930,000
| New | +$7.34M |
|
72
HilleVax
HLVX
$105M
| $6.71M | 0.2% |
406,024
| – | – |
|
73
Cabaletta Bio
CABA
$144M
| $5.99M | 0.18% |
724,777
+407,323
| +128% | +$3.37M |
|
|
AVDL
74
Avadel Pharmaceuticals
AVDL
$1.42B
| $5.4M | 0.16% |
+590,000
| New | +$5.4M |
|
75
Veru
VERU
$48.5M
| $4.99M | 0.15% |
4,298,212
-3,559,799
| -45% | -$4.13M |
|